|
"jia horng kao"的相关文件
显示项目 761-785 / 1180 (共48页)
<< < 26 27 28 29 30 31 32 33 34 35 > >>
每页显示[10|25|50]项目
| 臺大學術典藏 |
2018-09-10T18:03:51Z |
Daclatasvir/asunaprevir/beclabuvir, all-oral, fixed-dose combination for patients with chronic hepatitis C virus genotype 1
|
Kao, J.-H.;Yu, M.-L.;Peng, C.-Y.;Heo, J.;Chu, C.-J.;Chang, T.-T.;Lee, Y.-J.;Hu, T.-H.;Yoon, K.T.;Paik, S.W.;Lim, Y.S.;Ahn, S.H.;Isakov, V.;Mcphee, F.;Hu, W.;Scott Swenson, E.;Yin, P.D.;Treitel, M.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:03:51Z |
HBV markers for HCC prediction: Three heads are better than two?
|
Tseng, T.-C.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:03:51Z |
Hepatitis B virus infection and decreased risk of nonalcoholic fatty liver disease: A cohort study
|
Wang, C.-C.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:03:51Z |
Historical epidemiology of hepatitis C virus in select countries�Xvolume 4
|
Maaroufi, A.;Vince, A.;Himatt, S.M.;Mohamed, R.;Fung, J.;Opare-Sem, O.;Workneh, A.;Njouom, R.;Al Ghazzawi, I.;Abdulla, M.;Kaliaskarova, K.S.;Owusu-Ofori, S.;Abdelmageed, M.K.;Adda, D.;Akin, O.;Al Baqali, A.;Al Dweik, N.;Al Ejji, K.;Al Kaabi, S.;Al Naamani, K.;Al Qamish, J.;Al Sadadi, M.;Al Salman, J.;Albadri, M.;Al-Busafi, S.A.;Al-Romaihi, H.E.;Ampofo, W.;Antonov, K.;Anyaike, C.;Arome, F.;Bane, A.;Blach, S.;Borodo, M.M.;Brandon, S.M.;Bright, B.;Butt, M.T.;Cardenas, I.;Chan, H.L.Y.;Chen, C.J.;Chen, D.S.;Chen, P.J.;Chien, R.N.;Chuang, W.L.;Cuellar, D.;Derbala, M.;Elbardiny, A.A.;Estes, C.;Farag, E.;Gamkrelidze, I.;Garcia, V.;Genov, J.;Ghandour, Z.;Ghuloom, M.;Gomez, B.;Gunter, J.;Habeeb, J.;Hajelssedig, O.;Hamoudi, W.;Hrstic, I.;Hu, C.C.;Huang, C.F.;Hui, Y.T.;Jahis, R.;Jelev, D.;John, A.K.;Kamel, Y.;Kao, J.H.;Khamis, J.;Khattabi, H.;Khoudri, I.;Konysbekova, A.;Kotzev, I.;Lai, M.S.;Lao, W.C.;Layden, J.;Lee, M.H.;Lesi, O.;Li, M.;Lo, A.;Loo, C.K.;Luk?I?, B.;Malu, A.O.;Mateva, L.;Mitova, R.;Morovi?, M.;Murphy, K.;Mustapha, B.;Nde, H.;Nersesov, A.;Ngige, E.;Njoya, O.;Nonkovi?, D.;Obekpa, S.;Oguche, S.;Okolo, E.E.;Omede, O.;Omuemu, C.;Ondoa, P.;Phillips, R.O.;Prokopenko, Y.N.;Razavi, H.;Razavi-Shearer, D.;Redae, B.;Reic, T.;Rinke De Wit, T.;Rios, C.;Robbins, S.;Roberts, L.R.;Sanad, S.J.;Schmelzer, J.D.;Sharma, M.;Simonova, M.;Su, T.H.;Sultan, K.;Tan, S.S.;Tchernev, K.;Tsang, O.T.Y.;Tsang, S.;Tzeuton, C.;Ugoeze, S.;Uzochukwu, B.;Vi, R.;Wani, H.U.;Wong, V.W.S.;Yacoub, R.;Yesmembetov, K.I.;Youbi, M.;Yuen, M.F.;Razavi-Shearer, K.; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:03:51Z |
NOhep: Toward Global Control of Hepatitis B Virus Infection - An Introduction
|
Liu, C.-J.;Kao, J.-H.; CHUN-JEN LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:03:51Z |
Quantification of serum hepatitis B core antibody to predict off-entecavir relapse in patients with chronic hepatitis B
|
Tseng, C.-H.;Hsu, Y.-C.;Chang, C.-Y.;Tseng, T.-C.;Wu, M.-S.;Lin, J.-T.;Kao, J.-H.; MING-SHIANG WU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:03:51Z |
Serum viral load at the virological relapse predicts subsequent clinical flares in chronic hepatitis B patients off entecavir therapy
|
Hsu, Y.-C.;Mo, L.-R.;Chang, C.-Y.;Wu, M.-S.;Yang, T.-H.;Kao, J.-H.;Chen, C.-C.;Tseng, C.-H.;Tai, C.-M.;Lin, C.-W.;Wu, C.-Y.;Lin, J.-T.; MING-SHIANG WU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:03:50Z |
Elimination of Hepatitis B: Is It a Mission Possible?
|
Jia-Horng Kao; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:03:50Z |
Elimination of Hepatitis B: Is It a Mission Possible?
|
Jia-Horng Kao; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:03:50Z |
Letter: the influence of direct acting agents for hepatitis C, on hepatitis B reactivation
|
Jia-Horng Kao; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:03:50Z |
Letter: the influence of direct acting agents for hepatitis C, on hepatitis B reactivation
|
Jia-Horng Kao; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:03:50Z |
Natural history of acute and chronic hepatitis B: The role of HBV genotypes and mutants
|
Chih-Lin Lin;Jia-Horng Kao; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:03:50Z |
Natural history of acute and chronic hepatitis B: The role of HBV genotypes and mutants
|
Chih-Lin Lin;Jia-Horng Kao; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:03:47Z |
Fibrosis-4 Index Helps Identify HBV Carriers with the Lowest Risk of Hepatocellular Carcinoma
|
Tseng, T.-C. and Liu, C.-J. and Su, T.-H. and Yang, W.-T. and Chen, C.-L. and Yang, H.-C. and Wang, C.-C. and Kuo, S.F.-T. and Liu, C.-H. and Chen, P.-J. and Chen, D.-S. and Kao, J.-H.; HUNG-CHIH YANG; CHUN-JEN LIU; CHEN-HUA LIU; TUNG-HUNG SU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:03:47Z |
Hepatitis B virus reactivation in patients receiving interferon-free direct-acting antiviral agents for chronic hepatitis C virus infection
|
Liu, C.-H. and Liu, C.-J. and Su, T.-H. and Fang, Y.-J. and Yang, H.-C. and Chen, P.-J. and Chen, D.-S. and Kao, J.-H.; HUNG-CHIH YANG; CHUN-JEN LIU; CHEN-HUA LIU; TUNG-HUNG SU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:03:46Z |
Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients with Chronic Hepatitis C Virus Infection
|
Liu, C.-H.;Chen, Y.-S.;Wang, S.-S.;Liu, C.-J.;Su, T.-H.;Yang, H.-C.;Hong, C.-M.;Chen, P.-J.;Chen, D.-S.;Kao, J.-H.; HUNG-CHIH YANG; CHUN-JEN LIU; CHEN-HUA LIU; DING-SHINN CHEN; CHUN-MING HONG; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:02:16Z |
Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients
|
Lee, M.-H.;Huang, C.-F.;Lai, H.-C.;Lin, C.-Y.;Dai, C.-Y.;Liu, C.-J.;Wang, J.-H.;Huang, J.-F.;Su, W.-P.;Yang, H.-C.;Kee, K.-M.;Yeh, M.-L.;Chuang, P.-H.;Hsu, S.-J.;Huang, C.-I.;Kao, J.-T.;Chen, C.-C.;Chen, S.-H.;Jeng, W.-J.;Yang, H.-I.;Yuan, Y.;Lu, S.-N.;Sheen, I.-S.;Liu, C.-H.;Peng, C.-Y.;Kao, J.-H.;Yu, M.-L.;Chuang, W.-L.;Chen, C.-J.; HUNG-CHIH YANG; CHUN-JEN LIU; CHEN-HUA LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:01:01Z |
Treatment of de novo hepatitis C virus-related fibrosing cholestatic hepatitis after orthotopic heart transplantation by ledipasvir and sofosbuvir.
|
Chen-Hua Liu;Yih-Sharng Chen;Sheoi-Shen Wang;Jia-Horng Kao; CHEN-HUA LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:01:01Z |
Treatment of de novo hepatitis C virus-related fibrosing cholestatic hepatitis after orthotopic heart transplantation by ledipasvir and sofosbuvir.
|
Chen-Hua Liu;Yih-Sharng Chen;Sheoi-Shen Wang;Jia-Horng Kao; CHEN-HUA LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:00:57Z |
High serum lipopolysaccharide-binding protein level in chronic hepatitis C viral infection is reduced by anti-viral treatments
|
Nien, H.-C. and Hsu, S.-J. and Su, T.-H. and Yang, P.-J. and Sheu, J.-C. and Wang, J.-T. and Chow, L.-P. and Chen, C.-L. and Kao, J.-H. and Yang, W.-S.; JIN-CHUAN SHEU; LU-PING CHOW; WEI-SHIUNG YANG; TUNG-HUNG SU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:00:57Z |
Telbivudine therapy for chronic hepatitis B: A journey to identify super-responders and to optimize treatment using the roadmap model
|
Kao, J.-H.;Asselah, T.;Dou, X.-G.;Hamed, K.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:00:55Z |
Benefits of long-term therapy with nucleos(t)ide analogues in treatment-naive patients with chronic hepatitis B
|
Wei, L.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T15:37:36Z |
New perspectives of biomarkers for the management of chronic hepatitis B
|
Lin, C.-L.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T15:36:55Z |
Liver gene expression profiles correlate with virus infection and response to interferon therapy in chronic hepatitis B patients
|
Tu, Hui-Chu; Liu, Chun-Jen; Liu, Chun-Jen; Wu, Hui-Lin;Hsiao, Tzu-Hung;Chen, Pei-Jer;Wong, Siao-Han;Kao, Jia-Horng;Chen, Ding-Shinn;Lu, Jo-Yang;Lu, Tzu-Pin;Chen, Yidong;Chuang, Eric Y.;Tu, Hui-Chu;Liu, Chun-Jen; Wu, Hui-Lin; Hsiao, Tzu-Hung; Chen, Pei-Jer; Wong, Siao-Han; Kao, Jia-Horng; Chen, Ding-Shinn; Lu, Jo-Yang; Lu, Tzu-Pin; Chen, Yidong; Chuang, Eric Y.; Tu, Hui-Chu; Liu, Chun-Jen; Wu, Hui-Lin;Hsiao, Tzu-Hung;Chen, Pei-Jer;Wong, Siao-Han;Kao, Jia-Horng;Chen, Ding-Shinn;Lu, Jo-Yang;Lu, Tzu-Pin;Chen, Yidong;Chuang, Eric Y.;Tu, Hui-Chu;Liu, Chun-Jen; Wu, H.-L. and Hsiao, T.-H. and Chen, P.-J. and Wong, S.-H. and Kao, J.-H. and Chen, D.-S. and Lu, J.-Y. and Lu, T.-P. and Chen, Y. and Chuang, E.Y. and Tu, H.-C. and Liu, C.-J.; 陳定信;高嘉宏;盧子彬;吳慧琳;劉俊人;陳培哲; 陳定信;高嘉宏;劉俊人;陳培哲; 戴槐青; 余宏政; T.-P. LU; Wu, Hui-Lin; Tai, Huai-Ching; CHUN-JEN LIU; Hsiao, Tzu-Hung; Chung, Shiu-Dong; Chen, Pei-Jer; Chien, Chiang-Ting; DING-SHINN CHEN; Chen, Pei-Jer; Chen, Pei-Jer; JIA-HORNG KAO; Wong, Siao-Han; Wong, Siao-Han; Yu, Hong-Jeng; Kao, Jia-Horng; Kao, Jia-Horng; Kao, Jia-Horng; Chen, Ding-Shinn; Lu, Jo-Yang; Lu, Jo-Yang; T.-P. LU; Lu, Tzu-Pin; T.-P. LU; Chen, Yidong; Chen, Yidong; Chuang, Eric Y. |
| 臺大學術典藏 |
2018-09-10T15:35:17Z |
Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection.
|
Yang, Wan-Ting;Wu, Li-Wei;Tseng, Tai-Chung;Chen, Chi-Ling;Yang, Hung-Chih;Su, Tung-Hung;Wang, Chia-Chi;Kuo, Stephanie Fang-Tzu;Liu, Chen-Hua;Chen, Pei-Jer;Chen, Ding-Shinn;Liu, Chun-Jen;Kao, Jia-Horng; Wan-Ting Yang, Li-Wei Wu, Tai-Chung Tseng, Chi-Ling Chen, Hung-Chih Yang, Tung-Hung Su, Chia-Chi Wang, Stephanie Fang-Tzu Kuo, Chen-Hua Liu, Pei-Jer Chen, Ding-Shinn Chen, Chun-Jen Liu, Jia-Horng Kao; 劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳祈玲; HUNG-CHIH YANG; Yang, Wan-Ting; Wu, Li-Wei; CHUN-JEN LIU; Tseng, Tai-Chung; PEI-JER CHEN; Chen, Chi-Ling; CHEN-HUA LIU; DING-SHINN CHEN; Yang, Hung-Chih; TUNG-HUNG SU; Su, Tung-Hung; JIA-HORNG KAO; Wang, Chia-Chi; Kuo, Stephanie Fang-Tzu; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Liu, Chun-Jen; Kao, Jia-Horng |
显示项目 761-785 / 1180 (共48页)
<< < 26 27 28 29 30 31 32 33 34 35 > >>
每页显示[10|25|50]项目
|
